Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Anabolic steroid users may face higher risk of severe COVID-19.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Finasteride doesn't affect ovulation in normal women.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.